How do you think the new GigE standards will influence the machine vision industry?
Respond or ask your question now!
Earlier this month, Avantis demonstrated the Third Eye Retroscope at the Annual Scientific Meeting of the
"Over 20 million colonoscopy procedures are performed every year in the United States and at least twice that many worldwide," said Bruce Weyer , VicePresident of Marketing at OmniVision. "We're excited about the potentialhealth and procedural benefits of single-use disposable cameras in a number of medical applications and anticipate steady growth in the medical market for our image sensors in future years."
OmniVision Technologies designs and markets high-performance semiconductor image sensors. Its OmniPixel(R), OmniPixel2(TM), OmniPixel3(TM) andCameraChip(TM) products are highly integrated single-chip CMOS image sensorsfor mass-market consumer and commercial applications such as mobile phones,digital still cameras, security and surveillance systems, interactive videogames, laptops and PCs and automotive and medical imaging systems. Additional information is available at www.ovt.com.
About Avantis Medical Systems, Inc.
Avantis Medical Systems, Inc. is a medical device company founded todevelop and manufacture catheter-based endoscopic devices. Based in Sunnyvale ,CA, the Company's initial focus is on devices for use in detecting andtreating cancers of the gastrointestinal (GI) tract. The Avantis team has manydecades of experience in the medical device industry, and focuses ondeveloping solutions for problems, hazards and inconveniences associated withtraditional technologies. The Company is developing an extensive portfolio ofproducts based on the convergent technologies of micro-chips and reinforcedcatheters. Additional information is available at www.avantismedical.com.
Certain statements in this press release, including statements regardingthe performance and capabilities of and the anticipated demand for the OV6920CMOS image sensors are forward-looking statements that are subject to risksand uncertainties. These risks and uncertainties, which could cause theforward-looking statements and OmniVision's results to differ materially,include, without limitation: potential errors, design flaws or other problemswith the OV6920; customer acceptance, demand, and the other risks detailedfrom time to time in OmniVision's Securities and Exchange Commission filingsand reports, including, but not limited to, OmniVision's annual reports filedon Form 10-K and quarterly reports filed on Form 10-Q. OmniVision expresslydisclaims any obligation to update information contained in any forward-looking statement.